Nelotanserin is a selective 5-HT2A receptor inverse agonist that has been investigated for the treatment of various neuropsychiatric disorders, including sleep disturbances and behavioral symptoms associated… Read more
Nelotanserin is a selective 5-HT2A receptor inverse agonist that has been investigated for the treatment of various neuropsychiatric disorders, including sleep disturbances and behavioral symptoms associated with neurodegenerative conditions such as Parkinson’s disease dementia and Lewy body dementia. To support the rigorous analytical requirements of pharmaceutical development, laboratories rely on high-quality reference standards for Nelotanserin. This category includes comprehensive sets of impurity profiles, metabolites, and stable isotope labelled compounds, which are essential for precise analytical testing, method validation, and quality control. These materials provide the necessary benchmarks for drug substance and drug product analysis, ensuring accuracy in impurity identification, quantification, and bioanalytical studies. By utilizing these specialized standards, research and quality control teams can maintain the sensitivity and reliability required for pharmacokinetic assessments and regulatory compliance throughout the drug development process.